Life sciences regulatory & compliance partner Joshua Oyster and associate Rebecca Williams will present at the Food & Drug Law Institute Advertising & Promotion for Medical Products Conference on October 15 and 16th in Washington, D.C.
Joshua will moderate the panel “Exchanges of Scientific Information: A Closer Look at FDA’s Perspective.” The session will explore the impact of the FDA’s January 2025 final guidance regarding communications of scientific information on unapproved uses, the First Amendment addendum under the current administration, and how medical products companies should be adopting to the new landscape.
Rebecca will present on the panel “Influencer Endorsement of Rx Drugs: Regulatory Oversight Today.” The panel will examine regulations and guidelines for advertisements on various social media platforms, advertising of prescription drugs on telehealth platforms, recent FDA warning letters, and the impact of social media marketing on viewers.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.